Need Help?

Mult-omics Palbociclib Resistance Study in HR+/HER2– Metastatic Breast Cancer

Mult-omics Palbociclib Resistance Study in HR+/HER2– Metastatic Breast Cancer

Request Access

SMC Breast Cancer data transfer policy

To access raw data fastq, please contact SMC breast cancer DAC. (yhparkhmo@skku.edu or kyunghee.park@samsung.com). The process steps are: 1. Contact SMC breast cancer DAC to receive two applications. 1) Samsung Medical Center (SMC) Data Transfer Agreement (DTA) and 2) Questionnaire for DTA (Application form). 2. After reviewing the documents in your institution, fill in the blanks in two documents, sign and reply to SMC breast cancer DAC. 3. After receiving your signed documents, SMC internal committee will proceed with the approval process of data transfer. 4. SMC breast cancer DAC will contact EGA to grant access to the EGA dataset after obtaining permission from SMC internal committee.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001005736 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in